Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

27.25
Delayed Data
As of 12:26pm ET
 -0.1501 / -0.55%
Today’s Change
16.40
Today|||52-Week Range
37.36
+44.95%
Year-to-Date

Today’s Trading

Previous close27.40
Today’s open27.40
Day’s range26.85 - 28.55
Volume773,884
Average volume (3 months)688,907
Market cap$1.3B
Dividend yield--
Data as of 12:26pm ET, 02/28/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+314.24%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd+0.09+0.71%
TXMDTherapeuticsMD Inc-0.09-1.42%
EBSEmergent BioSolution...+0.89+2.91%
FWPForward Pharma A/S-0.10-0.36%
Data as of 12:40pm ET, 02/28/2017

Financials

Last reporting dateJanuary 9, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts


Search for Jobs